TEM: AI Healthcare Winner or a Stock Priced Too Far Ahead?
Tempus has real products and customers. The question is whether their value can overcome weak cash conversion, the cost of Personalis, and the expectations already in the stock.
- Price at analysis
- $71.41
- Base range
- $35-60